Idevax
Idevax develops and commercializes a medical device for standardized intradermal injections. The company focuses on enabling reliable skin drug delivery and dose-sparing vaccination strategies through device design, preclinical evaluation, regulatory conformity (CE Class IIa, ISO 13485), and scientific communication. Activities include preclinical testing, participation in clinical and veterinary use discussions, white papers, trial-kit distribution, and collaborative projects.
Industries
N/A
Products
VAX-ID (intradermal injection device)
A needle-adaptor device engineered to deliver controlled intradermal injections compatible with liquid-formulated vaccines; designed for standardized, reproducible intradermal administration with limited insertion depth intended to minimize pain.
VAX-ID (intradermal injection device)
A needle-adaptor device engineered to deliver controlled intradermal injections compatible with liquid-formulated vaccines; designed for standardized, reproducible intradermal administration with limited insertion depth intended to minimize pain.
Services
Trial kit provision for device evaluation
Supply of trial kits to allow external evaluation of intradermal injection devices.
Scientific collaboration and partnerships
Collaboration with research organizations, industry partners, and consortia to evaluate and deploy intradermal delivery solutions in public-health and therapeutic contexts.
Trial kit provision for device evaluation
Supply of trial kits to allow external evaluation of intradermal injection devices.
Scientific collaboration and partnerships
Collaboration with research organizations, industry partners, and consortia to evaluate and deploy intradermal delivery solutions in public-health and therapeutic contexts.
Expertise Areas
- Intradermal vaccine delivery
- Medical device design for injection systems
- Preclinical safety and performance testing
- Dose-sparing vaccination strategies
Key Technologies
- Intradermal injection adapters (needle-adaptor devices)
- Mini-needle low-depth injection technique
- Preclinical animal-model testing
- Dose-sparing intradermal administration